|
WO2019030371A1
|
|
Saccharomyces boulardii for the treatment of mood disorders
|
|
CA3065417A1
|
|
Treatment of diseases associated with a dysregulation of the mtor pathway
|
|
FR3051114A1
|
|
Compounds for the treatment of alzheimer's disease
|
|
FR3050641A1
|
|
Composition useful for preparing an ova
|
|
RU2714126C2
|
|
Compositions and methods of preventing infections
|
|
FR3016881A1
|
|
TREATMENT OF DEGENERESCENCES AND PHOTO-INDUCED LESIONS OF THE RETINA
|
|
EP2886116A1
|
|
Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
|
|
EP2875810A1
|
|
Pharmacological treatment of obsessive-compulsive disorder using Stiripentol or a similar compound
|
|
EP2870969A1
|
|
Pharmaceutical composition for reducing fat mass
|
|
FR3005577A1
|
|
Treatment of buccal inconfort
|
|
FR2972192A1
|
|
Pharmaceutical composition for the prevention or treatment of cancer
|
|
FR2955495A1
|
|
MEDICINE FOR THE REDUCTION OF CHOLESTEROLEMIA
|
|
SI2201950T1
|
|
Compounds and methods for treating autism spectrum disorders
|
|
FR2953412A1
|
|
MEDICAMENT FOR THE TREATMENT OF GASTROINTESTINAL ULCERS
|
|
FR2953411A1
|
|
SYNERGISTIC COMBINATION OF ANALGESIC COMPOUNDS
|
|
EP2179734A1
|
|
Benzoxazine and dihydroquinazoline derivatives for use in the treatment of alcohol withdrawal syndrome
|
|
FR2943246A1
|
|
COMPOUND FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIES
|
|
FR2937553A1
|
|
SYNERGISTIC COMBINATION OF ANALGESIC COMPOUNDS
|
|
JP2009001560A
|
|
New method for synthesizing fluoroquinolone
|
|
FR2930891A1
|
|
Anti-amnesian compounds and pharmaceutical compositions comprising the same
|
